Ibogaine Archives - Page 2 of 5

Psychedelics Policy Newsletter: FDA prioritizes drug reform for psychedelics, Texas advances ibogaine research, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — June 2025

Commentary by Gregory Ferenstein

Texas Senate Bill 2308 could advance ibogaine as a treatment for opioid use disorder

Testimony by Madison Carlino

Psychedelics Policy Newsletter: Reforms for Congress, data for rescheduling, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — April 2025

Commentary by Gregory Ferenstein

Nevada Assembly Bill 378 could help patients access psychedelic therapies

Testimony by Madison Carlino

Legislative approaches that could improve access to psychedelic-based medicine

Testimony by Geoffrey Lawrence, Leonard Gilroy and Gregory Ferenstein

RFK Jr.’s opioid crisis plan

Commentary by Layal Bou Harfouch

Washington has a chance to examine ibogaine-assisted therapy benefits

Testimony by Madison Carlino

More Ibogaine